Accelerated aging during chronic oxidative stress: A role for PARP-1

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Boesten, Daniëlle M P H J ^a   De Vos Houben, Joyce M J ^a   Timmermans, Leen ^a   Den Hartog, Gertjan J M ^a   Bast, Aalt ^a   Hageman, Geja J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; CELL CULTURE; CELL PROLIFERATION; DISEASES; METHYLATION; OXIDATIVE STRESS;

ACCELERATED AGING; CELLULAR SENESCENCE; CHRONIC INFLAMMATORY DISEASE; CHRONIC OXIDATIVE STRESS; LINEAR CHROMOSOME; POLY(ADP-RIBOSE)-POLYMERASE 1 (PARP-1); STRONG CORRELATION; TERT-BUTYLHYDROPEROXIDE;

CHROMOSOMES;

FISETIN; MINOCYCLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TERT BUTYL HYDROPEROXIDE; FLAVONOID; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); TELOMERASE;

ARTICLE; CELL AGING; CHRONIC STRESS; CONTROLLED STUDY; DNA METHYLATION; ENZYME INHIBITION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PHARMACOLOGICAL BLOCKING; PROTEIN FUNCTION; SUBTELOMERIC METHYLATION; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE LENGTH; TELOMERE SHORTENING; CHROMOSOME 2; DRUG EFFECT; ENZYMOLOGY; FIBROBLAST; HELA CELL LINE; METABOLISM; PATHOLOGY;

CELL AGING; CHROMOSOMES, HUMAN, PAIR 2; DNA METHYLATION; FIBROBLASTS; FLAVONOIDS; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; MINOCYCLINE; OXIDATIVE STRESS; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS; TERT-BUTYLHYDROPEROXIDE;

EID: 84890035030     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/680414     Document Type: Article

References (68)

1. Whiting D. R., Guariguata L., Weil C., Shaw J., IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice 2011 94 3 311 321 2-s2.0-82955247909 10.1016/j.diabres.2011.10.029
2. Shaw J. E., Sicree R. A., Zimmet P. Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010 87 1 4 14 2-s2.0-73749083481 10.1016/j.diabres.2009.10.007
3. Houben J. M. J., Moonen H. J. J., van Schooten F. J., Hageman G. J., Telomere length assessment: biomarker of chronic oxidative stress? Free Radical Biology and Medicine 2008 44 3 235 246 2-s2.0-38149016212 10.1016/j. freeradbiomed.2007.10.001
4. Veryan C., Christopher P. N., Eva A., Identification of seven loci affecting mean telomere length and their association with disease. Nature Genetics 2013 45 422 427
5. Harley C. B., Futcher A. B., Greider C. W., Telomeres shorten during ageing of human fibroblasts. Nature 1990 345 6274 458 460 2-s2.0-0025279931 10.1038/345458a0 (Pubitemid 20178256)
6. Blackburn E. H., Structure and function of telomeres. Nature 1991 350 6319 569 573 2-s2.0-0025731583 10.1038/350569a0 (Pubitemid 21912269)
7. Rhee D. B., Ghosh A., Lu J., Bohr V. A., Liu Y., Factors that influence telomeric oxidative base damage and repair by DNA glycosylase OGG1. DNA Repair 2011 10 1 34 44 2-s2.0-78650419603 10.1016/j.dnarep.2010.09.008
8. von Zglinicki T., Oxidative stress shortens telomeres. Trends in Biochemical Sciences 2002 27 7 339 344 2-s2.0-0036629255 10.1016/S0968-0004(02) 02110-2 (Pubitemid 34756516)
9. Hewitt G., Jurk D., Marques F. D. M., Correia-Melo C., Hardy T., Gackowska A., Anderson R., Taschuk M., Mann J., Passos J. F., Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nature Communications 2012 3, article 708 2-s2.0-84857715451 10.1038/ncomms1708
10. Petersen S., Saretzki G., von Zglinicki T., Preferential accumulation of single-stranded regions in telomeres of human fibroblasts. Experimental Cell Research 1998 239 1 152 160 2-s2.0-0031821009 10.1006/excr.1997.3893 (Pubitemid 28368486)
11. Houben J. M. J., Mercken E. M., Ketelslegers H. B., Bast A., Wouters E. F., Hageman G. J., Schols A. M. W. J., Telomere shortening in chronic obstructive pulmonary disease. Respiratory Medicine 2009 103 2 230 236 2-s2.0-58249084014 10.1016/j.rmed.2008.09.003
12. Savale L., Chaouat A., Bastuji-Garin S., Marcos E., Boyer L., Maitre B., Sarni M., Housset B., Weitzenblum E., Matrat M., Corvoisier P. L., Rideau D., Boczkowski J., Dubois-Randé J.-L., Chouaid C., Adnot S., Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2009 179 7 566 571 2-s2.0-65249172518 10.1164/rccm.200809-1398OC
13. Adaikalakoteswari A., Balasubramanyam M., Mohan V., Telomere shortening occurs in Asian Indian Type 2 diabetic patients. Diabetic Medicine 2005 22 9 1151 1156 2-s2.0-24044458568 10.1111/j.1464-5491.2005.01574.x (Pubitemid 41224172)
14. Aviv A., Chronology versus biology: telomeres, essential hypertension, and vascular aging. Hypertension 2002 40 3 229 232 2-s2.0-0036712068 10.1161/01.HYP.0000027280.91984.1B (Pubitemid 35006702)
15. Benetos A., Gardner J. P., Zureik M., Labat C., Xiaobin L., Adamopoulos C., Temmar M., Bean K. E., Thomas F., Aviv A., Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension 2004 43 2 182 185 2-s2.0-10744225878 10.1161/01.HYP.0000113081.42868.f4 (Pubitemid 38174171)
16. Kinouchi Y., Hiwatashi N., Chida M., Nagashima F., Takagi S., Maekawa H., Toyota T., Telomere shortening in the colonic mucosa of patients with ulcerative colitis. Journal of Gastroenterology 1998 33 3 343 348 2-s2.0-0031745857 10.1007/s005350050094 (Pubitemid 28263648)
17. Rode L., Bojesen S. E., Weischer M., Vestbo J., Nordestgaard B. G., Short telomere length, lung function and chronic obstructive pulmonary disease in 46 396 individuals. Thorax 2013 68 429 435
18. Salpea K. D., Talmud P. J., Cooper J. A., Maubaret C. G., Stephens J. W., Abelak K., Humphries S. E., Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 2010 209 1 42 50 2-s2.0-77049106292 10.1016/j.atherosclerosis.2009.09.070
19. Steinert S., Shay J. W., Wright W. E., Modification of subtelomeric DNA. Molecular and Cellular Biology 2004 24 10 4571 4580 2-s2.0-2942617298 10.1128/MCB.24.10.4571-4580.2004 (Pubitemid 44109139)
20. Gonzalo S., Jaco I., Fraga M. F., Chen T., Li E., Esteller M., Blasco M. A., DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nature Cell Biology 2006 8 4 416 424 2-s2.0-33645702660 10.1038/ncb1386
21. Benetti R., García-Cao M., Blasco M. A., Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nature Genetics 2007 39 2 243 250 2-s2.0-33846590977 10.1038/ng1952 (Pubitemid 46184357)
22. Ohki R., Ishikawa F., Telomere-bound TRF1 and TRF2 stall the replication fork at telomeric repeats. Nucleic Acids Research 2004 32 5 1627 1637 2-s2.0-2942569579 10.1093/nar/gkh309 (Pubitemid 38832708)
23. Pacher P., Szabo C., Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. American Journal of Pathology 2008 173 1 2 13 2-s2.0-46749118458 10.2353/ajpath.2008.080019 (Pubitemid 351947950)
24. Kraus W. L., Hottiger M. O., PARP-1 and gene regulation: progress and puzzles. Molecular Aspects of Medicine 2013 10.1016/j.mam.2013.01.005
25. Hassa P. O., Hottiger M. O., A role of poly (ADP-Ribose) polymerase in NF- B transcriptional activation. Biological Chemistry 1999 380 7-8 953 959 2-s2.0-0032863224 10.1515/BC.1999.118 (Pubitemid 29412755)
26. Andreone T. L., O'Connor M., Denenberg A., Hake P. W., Zingarelli B., Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts. Journal of Immunology 2003 170 4 2113 2120 2-s2.0-0037442006 (Pubitemid 36197434)
27. Cawthon R. M., Telomere measurement by quantitative PCR. Nucleic Acids Research 2002 30 10, article e47 2-s2.0-2342419515
28. Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L. C., Coviello G. M., Wright W. E., Weinrich S. L., Shay J. W., Specific association of human telomerase activity with immortal cells and cancer. Science 1994 266 5193 2011 2015 2-s2.0-0028564951
29. Lee M. E., Rha S. Y., Jeung H.-C., Chung H. C., Oh B.-K., Subtelomeric DNA methylation and telomere length in human cancer cells. Cancer Letters 2009 281 1 82 91 2-s2.0-67349268468 10.1016/j.canlet.2009.02.031
30. 2: senescence- like growth arrest or apoptosis? Cell Growth and Differentiation 1997 8 5 589 598 2-s2.0-0030911124 (Pubitemid 27273070)
31. Hix S., Kadiiska M. B., Mason R. P., Augusto O., In vivo metabolism of tert-Butyl hydroperoxide to methyl radicals. EPR spin-trapping and DNA methylation studies. Chemical Research in Toxicology 2000 13 10 1056 1064 2-s2.0-0033789365 10.1021/tx000130l
32. Yang Q., Cellular senescence, telomere recombination and maintenance. Cytogenetic and Genome Research 2009 122 3-4 211 218 2-s2.0-59649109187 10.1159/000167806
33. Akimcheva S., Zellinger B., Riha K., Genome stability in Arabidopsis cells exhibiting alternative lengthening of telomeres. Cytogenetic and Genome Research 2009 122 3-4 388 395 2-s2.0-59649116918 10.1159/000167827
34. Dunham M. A., Neumann A. A., Fasching C. L., Reddel R. R., Telomere maintenance by recombination in human cells. Nature Genetics 2000 26 4 447 450 2-s2.0-0033672470 10.1038/82586
35. Hande M. P., Balajee A. S., Tchirkov A., Wynshaw-Boris A., Lansdorp P. M., Extra-chromosomal telomeric DNA in cells from Atm-/- mice and patients with ataxia-telangiectasia. Human Molecular Genetics 2001 10 5 519 528 2-s2.0-0035282711 (Pubitemid 32181675)
36. Vidaček N. Š., Ćukušić A., Ivanković M., Fulgosi H., Huzak M., Smith J. R., Rubelj I., Abrupt telomere shortening in normal human fibroblasts. Experimental Gerontology 2010 45 3 235 242 2-s2.0-76749134212 10.1016/j.exger.2010.01.009
37. Khan N., Syed D. N., Ahmad N., Mukhtar H., Fisetin: a dietary antioxidant for health promotion. Antioxidants & Redox Signaling 2013 19 2 151 162 10.1089/ars.2012.4901
38. Maher P., Akaishi T., Abe K., Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proceedings of the National Academy of Sciences of the United States of America 2006 103 44 16568 16573 2-s2.0-33750832268 10.1073/pnas.0607822103 (Pubitemid 44715236)
39. de Sousa R. R. R., Queiroz K. C. S., Souza A. C. S., Gurgueira S. A., Augusto A. C., Miranda M. A., Peppelenbosch M. P., Ferreira C. V., Aoyama H., Phosphoprotein levels, MAPK activities and NF kB expression are affected by fisetin. Journal of Enzyme Inhibition and Medicinal Chemistry 2007 22 4 439 444 2-s2.0-34547760465 10.1080/14756360601162063 (Pubitemid 47225706)
40. Geraets L., Moonen H. J. J., Brauers K., Wouters E. F. M., Bast A., Hageman G. J., Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose) polymerase-1 in pulmonary epithelial cells. Journal of Nutrition 2007 137 10 2190 2195 2-s2.0-34948888880 (Pubitemid 47529575)
41. Sengupta B., Pahari B., Blackmon L., Sengupta P. K., Prospect of bioflavonoid fisetin as a quadruplex DNA ligand: a biophysical approach. PLoS ONE 2013 8 e65383
42. Wang Q., Liu J.-Q., Chen Z., Zheng K.-W., Chen C.-Y., Hao Y.-H., Tan Z., G-quadruplex formation at the 3′ end of telomere DNA inhibits its extension by telomerase, polymerase and unwinding by helicase. Nucleic Acids Research 2011 39 14 6229 6237 2-s2.0-80051762076 10.1093/nar/gkr164
43. Gomez D., Mergny J.-L., Riou J.-F., Detection of telomerase inhibitors based on G-quadruplex ligands by a modified telomeric repeat amplification protocol assay. Cancer Research 2002 62 12 3365 3368 2-s2.0-0037096736 (Pubitemid 34651379)
44. Oganesian L., Bryan T. M., Physiological relevance of telomeric G-quadruplex formation: a potential drug target. BioEssays 2007 29 2 155 165 2-s2.0-33847372902 10.1002/bies.20523 (Pubitemid 46340250)
45. Krady J. K., Basu A., Allen C. M., Xu Y., LaNoue K. F., Gardner T. W., Levison S. W., Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005 54 5 1559 1565 2-s2.0-17844392902 10.2337/diabetes.54.5.1559 (Pubitemid 40586690)
46. Alano C. C., Kauppinen T. M., Valls A. V., Swanson R. A., Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proceedings of the National Academy of Sciences of the United States of America 2006 103 25 9685 9690 2-s2.0-33745457705 10.1073/pnas.0600554103 (Pubitemid 43955885)
47. Du Y., Ma Z., Lin S., Dodel R. C., Gao F., Bales K. R., Triarhou L. C., Chernet E., Perry K. W., Nelson D. L. G., Luecke S., Phebus L. A., Bymaster F. P., Paul S. M., Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2001 98 25 14669 14674 2-s2.0-0035807904 10.1073/pnas.251341998 (Pubitemid 33121449)
48. Wu D. C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.-K., Ischiropoulos H., Przedborski S., Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. Journal of Neuroscience 2002 22 5 1763 1771 2-s2.0-0036522967 (Pubitemid 35386294)
49. Zhu S., Stavrovskaya I. G., Drozda M., Kim B. Y. S., Ona V., Li M., Sarang S., Liu A. S., Hartley D. M., Wu D. C., Guilans S., Ferrante R. J., Przedborski S., Kristal B. S., Friedlander R. M., Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002 417 6884 74 78 2-s2.0-0037007645 10.1038/417074a (Pubitemid 34498818)
50. Van Den Bosch L., Tilkin P., Lemmens G., Robberecht W., Minocycline delays disease onset and mortality in a transgenic model of ALS. NeuroReport 2002 13 8 1067 1070 2-s2.0-0037067009 (Pubitemid 34587742)
51. Chen M., Ona V. O., Li M., Ferrante R. J., Fink K. B., Zhu S., Bian J., Guo L., Farrell L. A., Hersch S. M., Hobbs W., Vonsattei J.-P., Cha J.-H. J., Friedlander R. M., Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nature Medicine 2000 6 7 797 801 2-s2.0-0033912716 10.1038/77528 (Pubitemid 30469429)
52. Lampl Y., Boaz M., Gilad R., Lorberboym M., Dabby R., Rapoport A., Anca-Hershkowitz M., Sadeh M., Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 2007 69 14 1404 1410 2-s2.0-34848857092 10.1212/01.wnl.0000277487.04281.db (Pubitemid 47511461)
53. Emerit J., Edeas M., Bricaire F., Neurodegenerative diseases and oxidative stress. Biomedicine and Pharmacotherapy 2004 58 1 39 46 2-s2.0-1642483509 10.1016/j.biopha.2003.11.004 (Pubitemid 38117047)
54. Li F., Szabó C., Pacher P., Southan G. J., Abatan O. I., Charniauskaya T., Stevens M. J., Obrosova I. G., Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Diabetologia 2004 47 4 710 717 2-s2.0-2442651710 10.1007/s00125-004-1356-0 (Pubitemid 38658373)
55. Szabó C., Biser A., Benko R., Böttinger E., Suszták K., Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice. Diabetes 2006 55 11 3004 3012 2-s2.0-33845529318 10.2337/db06-0147 (Pubitemid 44923636)
56. Brownlee M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005 54 6 1615 1625 2-s2.0-20044376702 10.2337/diabetes.54. 6.1615 (Pubitemid 40770750)
57. Sinha-Hikim I., Shen R., Nzenwa I., Gelfand R., Mahata S. K., Sinha-Hikim A. P., Minocycline suppresses oxidative stress and attenuates fetal cardiac myocyte apoptosis triggered by in utero cocaine exposure. Apoptosis 2011 16 6 563 573 2-s2.0-79955836417 10.1007/s10495-011-0590-4
58. Beneke S., Cohausz O., Malanga M., Boukamp P., Althaus F., Bürkle A., Rapid regulation of telomere length is mediated by poly(ADP-ribose) polymerase-1. Nucleic Acids Research 2008 36 19 6309 6317 2-s2.0-56049100464 10.1093/nar/gkn615
59. Howitz K. T., Bitterman K. J., Cohen H. Y., Lamming D. W., Lavu S., Wood J. G., Zipkin R. E., Chung P., Kisielewski A., Zhang L.-L., Scherer B., Sinclair D. A., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003 425 6954 191 196 2-s2.0-0141719702 10.1038/nature01960 (Pubitemid 37150899)
60. 2 and Wnt/EGFR/NF- B-signaling pathways. Carcinogenesis 2009 30 2 300 307 2-s2.0-60149112516 10.1093/carcin/bgn269
61. Kim S. R., Park J. H., Lee M. E., Park J. S., Park S. C., Han J. A., Selective COX-2 inhibitors modulate cellular senescence in human dermal fibroblasts in a catalytic activity-independent manner. Mechanisms of Ageing and Development 2008 129 12 706 713 2-s2.0-56949107189 10.1016/j.mad.2008.09.003
62. Blasco M. A., The epigenetic regulation of mammalian telomeres. Nature Reviews Genetics 2007 8 4 299 309 2-s2.0-33947317206 10.1038/nrg2047 (Pubitemid 46439289)
63. Guan J. Z., Guan W. P., Maeda T., Makino N., The subtelomere of short telomeres is hypermethylated in Alzheimer's disease. Aging and Disease 2012 3 164 170
64. Maeda T., Guan J. Z., Oyama J.-I., Higuchi Y., Makino N., Aging-associated alteration of subtelomeric methylation in Parkinson's disease. Journals of Gerontology A 2009 64 9 949 955 2-s2.0-68949123246 10.1093/gerona/glp070
65. Caiafa P., Guastafierro T., Zampieri M., Epigenetics: Poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns. FASEB Journal 2009 23 3 672 678 2-s2.0-61449261908 10.1096/fj.08-123265
66. Caiafa P., Zlatanova J., CCCTC-binding factor meets poly(ADP-ribose) polymerase-1. Journal of Cellular Physiology 2009 219 2 265 270 2-s2.0-62149087062 10.1002/jcp.21691
67. Reale A., De Matteis G., Galleazzi G., Zampieri M., Caiafa P., Modulation of DNMT1 activity by ADP-ribose polymers. Oncogene 2005 24 1 13 19 2-s2.0-12444253985 10.1038/sj.onc.1208005 (Pubitemid 40143860)
68. Won J. L., Shim J.-Y., Zhu B. T., Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Molecular Pharmacology 2005 68 4 1018 1030 2-s2.0-25144507259 10.1124/mol.104.008367 (Pubitemid 41345793)